Darunavir - Dosages, Indications, Contraindications, Pharmacology, and Side Effects

Overview

Darunavir is a medicine used to help people who have HIV, a virus that makes the body weak. It belongs to a group of medicines called protease inhibitors. Darunavir is usually given together with another medicine like Ritonavir so it can work better.

This medicine cannot cure HIV, but it helps stop the virus from growing. This keeps people healthier for a longer time and lowers the chances of getting sick from other infections or certain cancers.

Darunavir was approved for use in the United States in 2006 and in Europe in 2007. It is also on an important list of medicines that the World Health Organization says are essential for good healthcare.

How Does Darunavir Work?

Darunavir belongs to a class of drugs called protease inhibitors. These drugs reduce the amount of HIV in the bloodstream and elevate the CD4 cell concentration by suppressing the growth of the HIV protease enzyme.

The human immunodeficiency virus largely relies on this enzyme to multiply and progress. Therefore, when conjugated with boosting drugs, Darunavir treats and prevents human immunodeficiency virus infection and acquired immunodeficiency syndrome.

Drug dosage for HIV infection:

Darunavir is used in coadministration with Ritonavir or additional antiretroviral agents. So, doctors generally prescribe these doses.

• Darunavir 800 mg and Ritonavir 100 mg oral tablets once daily with food for treatment-naive people (antiretroviral experienced).

• In another way, Darunavir 600 mg with Ritonavir 100 mg tablets once every 12 hours with food for treatment-experienced people.

What Are the Precautions and Warnings of the Drug Darunavir?

Precautions and Warnings of the Drug Darunavir:

• Allergy: Darunavir and its component sulpha can precipitate severe and potentially life-threatening allergic skin reactions. The signs include rash, swelling of the face or lips, and trouble breathing. One should seek a doctor or emergency care. One should not retake the medication with a history of allergy, as it would lead to complications.

• Pregnancy: No adequate or appropriate data from studies determine the drug-associated risk in pregnant women. But it is considered safe. However, like all drug therapies, considerations should be taken with Darunavir during pregnancy. So, inform the doctor about the pregnancy or a plan for pregnancy.

• Breastfeeding: The studies validating the use and its risk during breastfeeding are inadequate, but one must be cautious and inform the physician when breastfeeding. So, discontinuing either breastfeeding or the drug is advised since the drug passes through.

• Children: Darunavir is not recommended or advised for infants under three years of age.

For Patients

Role of Darunavir in HIV and AIDS:

Unfortunately, there is no permanent cure for this deadly disease, HIV infection. However, certain treatments are prescribed to control HIV infection. These treatment options, specifically antiretroviral therapy, help people live prolonged and more productive lives.

HIV causes infection with the help of the HIV protease enzyme and thus deteriorates the CD4 cell levels, invading the immune system. Darunavir is a protease inhibitor that inhibits the enzyme and increases the CD4 cell concentrations. Therefore, the HIV in the system is diminished.

How to Take Darunavir?

• Darunavir is available in specific dosages and formulations.

• It is usually prescribed along with certain medications that enhance its levels and effectiveness, along with other antiretroviral drugs.

• Healthcare professionals determine the correct dosage and form based on age, severity of HIV infection, and underlying medical conditions.

• The drug may affect individuals differently, so it should be taken exactly as instructed.

• Following the prescribed directions helps achieve full benefits while minimizing side effects.

• The medication comes with manufacturer instructions. Read the label carefully and consult healthcare professionals if you have any questions.

Things to inform the doctor:

• Tell your doctor if you are allergic to Darunavir or sulfa medicines (drugs containing a sulfur-based chemical).

• Inform the doctor about any allergy to other ingredients in the medicine.

• Tell the doctor if you have any allergies to other medications.

• Share a complete list of all the medicines, vitamin supplements, and herbal products you take.

• Tell your doctor if you use hormonal contraceptives (birth control pills, rings, patches, implants, injections).

• Inform your doctor about any medical conditions, especially hemophilia (bleeding disorder), hepatitis, liver cirrhosis (severe liver scarring), other liver problems, cytomegalovirus infection (viral infection), pneumonia, or tuberculosis.

• Tell your doctor if you are pregnant, breastfeeding, or planning pregnancy.

Inform your doctor if you take or plan to take the following medications, as they can dangerously interact with Darunavir:

• Alfuzosin.

• Dronedarone.

• Elbasvir.

• Ergotamine/Dihydroergotamine/Methylergonovine (migraine/bleeding control).

• Lomitapide.

• Lovastatin.

• Simvastatin.

• Lurasidone.

• Pimozide.

• Midazolam.

• Sildenafil.

• Rifampin.

• St. John’s Wort.

• Anticoagulants.

• Digoxin.

• Diuretics.

• Itraconazole/Ketoconazole.

• Metoprolol.

• Timolol.

• Carvedilol.

• Betamethasone.

• Budesonide.

Proper use of Darunavir:

• Darunavir tablet is to be taken orally.

• Darunavir tablets should be taken along with boosting drugs such as Ritonavir or Cobicistat. So, take them as directed.

• The medication is generally advised to be taken with food.

• Swallow the capsule as a whole with a glass of water or milk. Do not chew or break them.

• Take Darunavir and its combination drugs around the same time every day.

• Take the doses per the physicians’ directions, such as the number of tablets, amounts, and length of time.

• Do not stop taking the medication without the doctor's consent.

• In addition, do not miss a dose or overdose on them. So, one should complete the drugs as prescribed, though with an improvement.

• Subsequently, call the doctor if there is no improvement, worsening of symptoms, or adverse effects.

Directions to take Darunavir oral suspension:

• Shake the Darunavir oral suspension before each use.

• One can use the oral dosing syringe to withdraw the appropriate amount of oral suspension.

• Then, ingest the suspension correctly from that oral disposal syringe.

• Wash and dry thoroughly after each suspension.

• Also, read the label instructions for precise directions.

Dietary consideration:

One can follow the routine diet until the doctor advises on restrictions. However, a well-balanced, healthy diet paves the way for good physical, emotional, and social states. Talk to healthcare professionals about ingesting grapefruit and grape drinks while taking this medication.

Storage:

• Store the Darunavir medications at room temperature, away from heat, moisture, and sunlight.

• So, save them between (20 and 25 degrees Celsius) 68 and 77 degrees Fahreinheit.

• Any medication should be stored away from the reach of children.

• Hence, fill them in a safe, tight container that little ones cannot reach. But, of course, this is supposed to be done with caution to safeguard them from drug poisoning.

How to Dispense With Darunavir?

• One should safely dispose of unused or expired medicines in a precise way so that little children, pets, and companions will not be exposed.

• The medication is not meant to be flushed in the toilet, thrown in the community garbage, or poured into the channel.

What if One Misses the Dose of Darunavir?

If one misses or halts the medication, there is no further improvement. So, take the missed dose right after the thought. In contrast, if it is almost time for the next one, skip the missed dose and proceed with the subsequent dose. Nevertheless, one should not take a double dose to compensate for the missed one.

In cases of overdose of Darunavir

Darunavir overdose leads to severe health effects among all the drug classes. The notable signs of Darunavir overdose are difficulty breathing, collapse, seizure, and inability to wake. In cases of excessive medication, go to the doctor immediately.

Side effects of Darunavir

Darunavir is considered safe and effective in conjunction with other drugs. It has certain side effects, but it is mild and usually resolves with time. If not, one must talk with the healthcare professionals.

• Headache.

• Diarrhea.

• Nausea.

• Vomiting.

• Dizziness

• Stomach pain.

• Constipation.

Serious side effects and considerations:

The drug Darunavir, an antiretroviral therapy, can result in severe adverse reactions in the system. So, seek professional help soon if the person encounters the following.

• Increased bleeding in hemophilia people. The signs include unusual bleeding from the nose, urine, cough, and gums.

• Skin rashes.

• Signs of diabetes or high blood sugar include excessive urination, increased thirst, weight loss, infections, and poor wound healing.

• Changes or excess body fat in specific regions, including the breast, upper back, and stomach.

• Changes in cholesterol levels.

• Liver concerns include chronic vomiting, abdominal pain, itching, fever, yellowish discoloration of the skin, and dark-colored urine.

• Changes in the immune system include fever, fatigue, muscle aches, joint pain, rashes, redness, and liver concerns.

Subsequently, one should stop the Darunavir medication and seek medical attention in cases of the following signs.

• Serious allergic reactions - Swelling of the throat and face, hives, and trouble breathing.

• Severe skin reactions - Blisters, peeling, and rashes.

• Signs of pancreatitis - Nausea, vomiting, and severe stomachache.

For Doctors

Clinical data of Darunavir:

• Generic name: Darunavir.

• Drug class: Antiretroviral drug.

• Chemical formula: C27H37N3O7S.

• Molar mass: 547.67 g.mol -1.

Indications of Darunavir:

Darunavir in coadministration with Ritonavir or other antiretroviral drugs is indicated for treating human immunodeficiency virus infection. So, it is widely used in the following ways.

• Children three years and above with HIV.

• Adults with HIV infection or AIDS.

Pharmacology of Darunavir

Mechanism of action of Darunavir:

Darunavir protease inhibitors target the HIV-1 protease enzyme, which the virus needs to grow and mature. It attaches to the enzyme and blocks its activity, stopping the virus from breaking down its proteins into usable pieces.

Because of this, the virus cannot complete its life cycle and produces immature, non-infectious particles. Darunavir can also bind flexibly to different parts of the enzyme, making it effective even against many drug-resistant forms of HIV.

Pharmacodynamics:

• Darunavir is an antiretroviral agent that inhibits the human immunodeficiency virus (HIV) protease and blocks viral replication.

• In cases where Darunavir is administered with Ritonavir as the combination treatment, the Darunavir drug noticeably diminishes the viral burden, increasing the CD4 cell levels.

• Therefore, the views on mortality and morbidity are significantly reduced.

Absorption:

• The overall bioavailability of a single dose of Darunavir is 37 percent.

• The bioavailability of the combination of Darunavir and 100 mg of Ritonavir is 82 percent.

• After oral administration, the peak plasma concentration Tmax is attained in about 2.5 to 4 hours.

Distribution:

• The volume of distribution of the combination antiretroviral treatment of Darunavir and Ritonavir is about 161.0 to 264.9 L, according to a study of volunteers.

• A further study on Darunavir's pharmacokinetics showed the distribution volume as 220 L.

• The plasma protein binding of Darunavir is relatively 95%.

• The drug Darunavir chiefly binds to plasma protein, specifically alpha one acid glycoprotein (AAG).

Metabolism:

• Darunavir is well-extensively oxidized and metabolized using CPY3A, a hepatic cytochrome enzyme.

• It is also well metabolized in unboosted people through isobutyl aliphatic hydroxylation, carbamate hydrolysis, glucuronidation, and benzylic aromatic hydroxylation.

Elimination:

• The single dose of Darunavir administration in conjunction with Ritonavir is thus eliminated and traced in the urine 14 % and feces 80 %.

Half-life and clearance:

• The terminal half-life of combination antiretroviral treatment, including Darunavir and Ritonavir, is relatively 15 hours.

• Darunavir presents a low clearance rate. Following intravenous administration, the renal clearance rate of Darunavir alone is 32.8 L. The clearance of a combination of Darunavir and Ritonavir, administered twice daily, is approximately 5.9 L/h.

Contraindications of Darunavir

The coadministration of Darunavir with Ritonavir is contraindicated with other drugs that are highly dependent on CYP3A for renal clearance. Subsequently, the particular combination is contraindicated with drugs exhibiting increased plasma concentrations and influencing severe life-threatening complications.

The following are the contraindicated and other associated drugs that can diminish the efficacy of Darunavir.

• Alpha-1 adrenoceptor antagonist- Alfuzosin.

• Anti-gout drugs such as Colchicine are contraindicated in hepatic and renal impairment.

• Antipsychotic drugs such as Pimozide and Lurasidone.

• Rifampin is an antimycobacterial drug.

• Ergot derivatives like Ergotamine, Methyergonavine, and Dihydroergotamine.

• Cardiac, such as Ivabradine, Dronedarone, and Ranolazine.

• Herbal supplement, St.John’s wort.

• Cisapride.

• Antivirals for hepatitis C - Elbasvir or Grazoprevir.

• Lipid-modifying agents such as Lovastatin, Lomitapide, and Simvastatin.

• Naloxegol is an opioid antagonist.

• Orally administered sedatives like Triazolam and Midazolam.

• PDE-5 inhibitor- Sildenafil is prescribed for pulmonary arterial hypertension.

Adverse effects:

The drug Darunavir increases the blood's total cholesterol and triglyceride concentrations. Subsequently, it shows side effects such as nausea, vomiting, anorexia, diarrhea, fatigue, and rash.

The drug also exhibits the following severe yet adverse reactions.

• Hepatic disorders (hepatotoxicity and acute hepatitis).

• Asthenia, an administration site reaction.

• Gastrointestinal disorders like dyspepsia, flatulence, and acute pancreatitis.

• Diabetes mellitus or hyperglycemia.

• Body fat redistribution.

• Musculoskeletal and connective tissue conditions, particularly osteonecrosis and myalgia.

• Immune system concerns, namely hypersensitivity reaction and hyperimmune reconstitution syndrome.

• Skin and subcutaneous tissue disorders, namely pruritus, urticaria, Stevens-Johnson syndrome, and angioedema.

• Hemophilia.

• Distorted dreams.

Essential considerations for Darunavir:

• Darunavir must be taken with Ritonavir to work effectively because Ritonavir helps increase its levels in the body.

• People with liver problems have a higher risk of serious liver-related side effects, so regular liver tests are important before and during treatment.

• Since Darunavir contains a sulfonamide (sulfa) component, doctors should be cautious when prescribing it to people with a sulfa allergy, although studies show similar reaction rates in both allergic and non-allergic individuals.

• The medication may cause severe skin reactions, often with fever or abnormal liver tests. Treatment should be stopped if such symptoms appear.

• Darunavir can increase blood sugar levels, which may worsen existing diabetes or cause new-onset diabetes.

• People with hemophilia may experience increased bleeding episodes when taking Darunavir or other protease inhibitors.

Possible drug interactions of Darunavir:

A few interactions are described below.

• Darunavir can interact with many medicines; some interactions may be serious.

• Some drugs (like benzodiazepines) may not work well when taken with Darunavir.

• Some combinations (like Alfuzosin and Darunavir) may cause unsafe drops in blood pressure.

• Medicines or herbs like Aluminum hydroxide or St. John’s Wort can lower Darunavir levels, making it less effective.

• Other drugs (like Verapamil) may increase in the body when taken with Darunavir, leading to more side effects.

How Far Have Clinical Trials Proven the Effects of Darunavir?

A clinical trial-based study was conducted to validate Darunavir's safety and efficacy in treating human immunodeficiency virus infection and acquired immunodeficiency syndrome. The clinical trial was intervention-based and randomized, with 120 participants. The HIV-infected patients were given Darunavir and Ritonavir at 800 mg and 100 mg, respectively. The dosage is given as monotherapy based on a switch-maintenance technique for patients receiving antiretroviral therapy. Follow-ups are done after 24 weeks to determine the viral load, efficacy, and adverse effects.

Results

• Darunavir therapy reduces the viral load when taken once daily in treatment-naive adults and twice daily in treatment-experienced adults.

• The medication is generally well-tolerated but may cause gastrointestinal disturbances and lipid abnormalities.

• Overall, Darunavir is considered a favorable and effective option in antiretroviral regimens for adults and children with HIV infection.